HAART changed natural course of infection with HIV, reduced the morbidity and mortality of AIDS patients. The lipodystrophy syndrome is long-term complication of antiretroviral therapy characterized by changes in body fat redistribution changes and metabolic abnormalities: insulin resistance, hyperglycemia, diabetes type 2, hypertriglyceridemia and hyperlipidemia. The pathogenesis is multifactorial due to interplay of viral, host and drug related factors. The HIV protease inhibitors and NRTI may play a pathogenic role. The potential risk factors include treatment with PIs and NTRIs, increasing age, gender and genetic predispositions.